Frontalis Botulinum Toxin
The Impact of Botulinum Toxin Injection in the Frontalis on Brow Height and Morphology: A Randomized Trial
Sponsor: St Joseph University, Beirut, Lebanon
A PHASE4 clinical study on Browlift, this trial is ongoing. The trial is conducted by St Joseph University, Beirut, Lebanon and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jul 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Jul 2017 — Jul 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- St Joseph University, Beirut, Lebanon
For direct contact, visit the study record on ClinicalTrials.gov .